Please login to the form below

Not currently logged in
Email:
Password:

US market

This page shows the latest US market news and features for those working in and with pharma, biotech and healthcare.

AZ cuts $1.5bn-plus deal to pass US drug rights to Sobi

AZ cuts $1.5bn-plus deal to pass US drug rights to Sobi

AZ cuts $1.5bn-plus deal to pass US drug rights to Sobi. ... the US market.

Latest news

  • Google boosts healthcare business with new hire Google boosts healthcare business with new hire

    Google boosts healthcare business with new hire. Tech giant shows ambition in US market. ... Feinberg will provide some valuable insight into how US health providers operate, which will help Google sell into this multi-billion dollar market.

  • Medical cannabis now available on prescription, for some Medical cannabis now available on prescription, for some

    in the US, setting up an imminent launch, and is waiting for a verdict from the European regulatory authorities early next year. ... Cowen &Co estimated recently that cannabis could be a $75bn market in the US alone by 2030, although Europe will be a

  • Amgen CEO says Aimovig is “one of most successful launches” Amgen CEO says Aimovig is “one of most successful launches”

    The Repatha discount comes as the US administration is ramping up the pressure on the biopharma industry on drug pricing, most recently proposing a reference pricing model to bring process closer ... Commenting on the overall environment and how it looks

  • Pfizer’s Prevnar-13 successor takes aim at Merck rival Pfizer’s Prevnar-13 successor takes aim at Merck rival

    Pfizer just got a leg-up in its race with Merck &Co to bring a new-generation pneumococcal vaccine to the US market after getting a breakthrough designation (BTD) for its ... candidate. The 20-valent vaccine – PF-06482077 – picked up the BTD from the

  • Sanofi swaps execs with Bayer, looks to staunch diabetes, cardio decline Sanofi swaps execs with Bayer, looks to staunch diabetes, cardio decline

    Dieter Weinand to be based in key US market. Sanofi has unveiled a major reorganisation of its business, creating a new global primary care business and a China and emerging markets ... The diabetes and cardiovascular division saw revenues decline 15% in

More from news
Approximately 1 fully matching, plus 823 partially matching documents found.

Latest Intelligence

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    For the US market, this would formerly have been seen as an outrageous idea, and US pharma CEOs and industry lobby group PhRMA have opposed the move. ... These battles over pricing and access in the US market remain among the biggest priorities for

  • China: AstraZeneca’s new engine for growth and innovation China: AstraZeneca’s new engine for growth and innovation

    So how long before China eclipses the European market as the second most important behind the US? ... Roxadustat is under accelerated review and, if approved, would also be the first locally- developed medicine to hit the Chinese market even before

  • Chinese biotech’s global ambitions Chinese biotech’s global ambitions

    The company has a PD-1 cancer immunotherapy, tislelizumab, in development in China, and believes it can compete in the market alongside multinationals MSD (Merck in the US) and BMS and ... Meanwhile, BeiGene is also looking to break into the still

  • Made in China Made in China

    and a series of sweeping reforms is now opening China’s pharma market to rapid modernisation. ... Doing business ethically and in a compliant way is incredibly important for us globally, not just in China.”.

  • Pharma deals continue to slide Pharma deals continue to slide

    In addition the US stock market excited by the prospect of changes in corporate tax and greater government investment driving growth has risen to new highs. ... 1, 410 (upfront 80). WuXi Biologics and Gloria Pharma (CN). Arcus Biosciences (US).

More from intelligence
Approximately 0 fully matching, plus 43 partially matching documents found.

Latest appointments

  • Industry round up: appointments Industry round up: appointments

    Prior to this, Jenkins spent 17 years at GlaxoSmithKline (GSK) in the UK and US. ... UK. Vu, whose new post will see him further expand Concept’s presence in the US market, joins the company with over 15 years’experience in both business development

  • Open Health creates new role Open Health creates new role

    Joining the agency with twenty years’biopharmaceutical industry experience, Jones’expertise lies in market access, therapy launch and patient centric services. ... Creating a unique role within our field of expertise will enable us to offer a market

  • W2O bolsters its commercialisation offering W2O bolsters its commercialisation offering

    W2O bolsters its commercialisation offering. Rita Glaze joins the firm as leader of value, pricing and market access practice. ... Joining the network from Edelman, Glaze previously led the design and implementation of its US market access communications

  • Amra appoints new VP of North American sales Jeremy Edwards Amra appoints new VP of North American sales Jeremy Edwards

    Body composition analysis group, Amra, has made a trio of new-hires to support its growth and expansion of its operations into the US. ... expand the US market.”.

  • Portland Health appoints Alfred Jackson as a partner Portland Health appoints Alfred Jackson as a partner

    He said: “The opportunity to help Portland expand its impressive health footprint to the US market is an incredible opportunity. ... agency experience, senior leadership and strategic relationships across the health and government sectors to deepen our

More from appointments
Approximately 1 fully matching, plus 24 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 14 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health Communications

Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics